Sandra D Comer, PhD
New York State Psychiatric Institute · NYSPI/CUMC · New York State Psychiatric Institute / Columbia University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sandra D Comer, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:25 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04458545 · Clinical Trials of Multivalent Opioid Vaccine ComponentsNew York State Psychiatric Institute · recruiting · Opioid-use Disorder · principal investigator
- Ph2NCT03415581 · Evaluation of Doxazosin to Alter the Abuse of OxycodoneNew York State Psychiatric Institute · terminated · Opioid-use Disorder · principal investigator
- Ph2NCT03389750 · A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.New York State Psychiatric Institute · completed · Opioid Use Disorder · principal investigator
- Ph2NCT03205423 · Medication Development for Opioid and Alcohol AbuseNew York State Psychiatric Institute · completed · Opioid-use Disorder, Alcohol Use Disorder · principal investigator
- Ph1/Ph2NCT02692157 · NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical StudyNew York State Psychiatric Institute · withdrawn · Opioid Use Disorder · principal investigator
- N/ANCT02535494 · Risks and Benefits of Naloxone PrescribingNew York State Psychiatric Institute · completed · Opioid Overdose · principal investigator
- Ph2NCT01740414 · Effects of Ibudilast on Oxycodone Self-administration in Opioid AbusersNew York State Psychiatric Institute · completed · Opioid Abuse, Opioid Dependence · principal investigator
- Ph2NCT00723177 · Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid WithdrawalNew York State Psychiatric Institute · completed · Opioid-Related Disorders · principal investigator
- Ph3NCT00710385 · Abuse Liability of Suboxone Versus SubutexNew York State Psychiatric Institute · completed · Opioid-related Disorders · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use DisordersU54DA037842 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Frances Rudnick Levin · fiscal years 2014 to 2018Named on NCT02692157
- Risk and Benefits of Overdose Education and Naloxone Prescribing to Heroin UsersR01DA035207 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI SANDRA D. COMER · fiscal years 2014 to 2018Named on NCT02535494
- Novel Medication Approaches for Substance AbuseP50DA009236 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Herbert David Kleber · fiscal years 1994 to 2013Named on NCT01740414, NCT00723177
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.